|
ABSTRACT
Title |
: |
COST-EFFECTIVENESS ANALYSIS OF ANTI-DIABETIC THERAPY IN A UNIVERSITY TEACHING HOSPITAL |
Authors |
: |
Giwa Abdulganiyu, Tayo Fola |
Keywords |
: |
Cost-Effectiveness Analysis, Pharmaco-Economics, Anti-Diabetic Therapy |
Issue Date |
: |
March 2014 |
Abstract |
: |
Purpose: To conduct cost-effectiveness analysis of anti-diabetic therapy in a University Teaching Hospital in 2010. Methods: A retrospective review of selected case-notes was conducted. World Health Organization Defined Daily Dose Method of evaluating drug use and probability method for potential effectiveness of anti-diabetic therapeutic options from literature analysis was employed in determining cost-effectiveness of each anti-diabetic therapeutic option identified from anti-diabetic drug utilization studies. Sample Size, n=1200. Subjects’ case-notes were selected by systematic random sampling (Sampling Interval = 1). Results: Glibenclamide (N1.76/unit of effectiveness) which was more cost-effective than chlopropamide (N2.97/unit of effectiveness) in the management of moderate hyperglycemia in non-obese Type II Diabetes Mellitus was more frequently prescribed (81.5%). Glibenclamide + Metformin (N7.63/unit of effectiveness) which was more frequently prescribed (92.5%) was not necessarily more cost-effective than Chlopropamide + Metformin (N9.76/unit of effectiveness) in the management of moderate hyperglycemia in obese Type II Diabetes- Mellitus. Biphasic Isophane Insulin (N12.65/unit of effectiveness) which was more cost-effective than soluble insulin + insulin zinc (N30.37/unit of effectiveness) in the management of serve hyperglycemia in non-obese Type II Diabetes Mellitus was less frequently prescribed (42.3%). Biphasic Isophane Insulin + Metformin (N15.91/unit of effectiveness ) which was more cost-effective than soluble insulin + insulin zinc + metformin (N34.45/ unit of effectiveness) in the management of severe hyperglycemia in obese Type II Diabetes Mellitus patients was less frequently prescribed (25%). Conclusions: Prescription of lees cost-effective anti-diabetic drugs was rampant in Hospitals. |
Page(s) |
: |
82-91 |
ISSN |
: |
0975-9492 |
Source |
: |
Vol. 5, No.3 |
|